Australia is in the grip of anxiety and depression, with 100,000 homeless people and a widening income gap, social researcher Hugh Mackay will tell an audience at UNSW's 2017 Gandhi Oration tonight.
The largest randomised control trial to evaluate the effectiveness of ketamine as a new treatment for major depression has begun across Australia and New Zealand.
An online program used to treat insomnia can also significantly reduce anxiety and depression with improvements persisting for at least six months, new research shows.
We should resist pressure to prescribe ketamine to treat depression until clinical trials on the drug's long-term safety and effectiveness are completed, a leading UNSW mental health expert says.
A $2.1 million grant from the National Health and Medical Research Council announced today will see UNSW Professor Colleen Loo lead Australia’s largest clinical trial of ketamine as a new treatment for major depression.
Melancholia needs to be recognised as a distinct psychiatric condition – not simply as a more severe expression of depression – if clinical and community awareness is to be improved, writes Gordon Parker.
Electroconvulsive therapy remains one of the most effective treatments for severe depression, but new UNSW research shows the gentler ultra-brief pulse stimulation can be just as effective.
While there may be a connection between inflammation and depression, one doesn’t necessarily lead to the other, write Gordon Parker and Ute Vollmer-Conna.
